FY27 Cxbladder Molecular Diagnostic Testing

Special Notice (Request for quotation) from 248-Network Contract Office 8 (36c248). Responses are due Nov 23, 2026 (2 days left).

Open to all (no set-aside)Any registered business can bid, large or small.Who qualifies
  • 2Days left to respond
  • 13 daysThis buyer usually gives
  • 31%Notices this buyer changes
  • $1.4MTypical award from this office

What BidCamel found about this buyer

  • This office usually gives bidders 13 days to respond; this notice gives 6 days.
  • It changed 31% of its 94 notices after posting, so check for amendments before you submit.
  • It has 12 open bids right now. See them all.
  • It has made 11 awards in our records, typically $1.4M.

Companies this office paid before

  • Five Cranes Llc: 2 awards, $14.9M total
  • Double Bar Blue Cord Jv 1, Llc: 1 award, $2.0M total
  • Culpepper & Associates Security Services Inc: 1 award, $1.6M total
  • Design Build Consortium, Llc: 1 award, $1.6M total
  • Petnet Solutions, Inc.: 1 award, $1.4M total

These are past winners at this office, not the winner of this exact contract.

Key details
Solicitation number
36C24827Q0133
NAICS code
621511 Medical Laboratories
Size standard for this code
41.5 million dollars in average annual revenue
Set-aside
Open to all (no set-aside)
Buying
Service
Place
Tampa, FL · Florida bids
Posted
Nov 16, 2026
Last changed
Nov 16, 2026
Contact
Contact details are on the SAM.gov notice. Open on SAM.gov

Description

The Department of Veterans Affairs, James A. Haley VA Medical Center s (JAHVAMC) intent to solicit sole source to Pacific Edge Diagnostics USA Ltd., for specialized reference laboratory services for Cxbladder molecular diagnostic testing. 1.OBJECTIVE: 1.1 JAHVAMC requires Cxbladder testing for patients with suspected urothelial carcinoma, a history of urothelial carcinoma, or urinary tract abnormalities that cannot be definitively classified by routine morphologic evaluation alone. Cxbladder testing evaluates urinary messenger RNA (mRNA) biomarkers associated with urothelial carcinoma and provides clinically relevant molecular information to support diagnostic clarification, risk stratification, surveillance, and informed treatment decisions. JAHVAMC seeks a firm fixed-price, cost-per-test contract consisting of one 12-month base period and four 12-month option periods. The Contractor shall furnish Cxbladder Triage® and Cxbladder Monitor® testing, including all required test kits, collection and shipping materials, specimen transportation, laboratory analysis, result reporting, technical support, and secure electronic access to finalized test results. 2. SCOPE: 2.1 The Contractor shall furnish all labor, materials, equipment, supplies, shipping services, technical expertise, reporting capabilities, and administrative support necessary to perform Cxbladder Triage and Cxbladder Monitor testing for JAHVAMC, located in Tampa, Florida. Cxbladder Triage and Cxbladder Monitor testing support the clinical evaluation and management of patients who may be at risk for urothelial carcinoma. 2.2 Cxbladder Triage assists clinicians in identifying patients who may require further diagnostic evaluation for urothelial carcinoma. The test supports risk assessment and may help reduce unnecessary invasive diagnostic procedures in patients with a low likelihood of malignancy. 2.3 Cxbladder Monitor supports surveillance of patients with a history of urothelial carcinoma by identifying molecular signals associated with possible recurrent or progressive disease. The test assists clinicians in determining the appropriate level and timing of follow-up evaluation. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. 2.4 Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this Special Notice. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 Medical Laboratories with a size standard of $36.5 Million. Any offeror capable of providing this service shall notify the Contracting Officer by email within seven (7) calendar days from the date of the publication of this special notice. *Responses must include written documentation from the OEM, Pacific Edge Diagnostics USA Ltd., showing your company is an authorized service provider. All information is to be submitted no later than 2:00 PM EST, on Tuesday, November 23, 2026, to: [email protected].

Read the full notice and attachments on SAM.gov

Similar open bids

All open bids for NAICS 621511

From SAM.gov and USAspending.gov public data. BidCamel adds the buyer and award facts.

Save and get alerts